Abstract
The objective of the present study was to determine the bacterial and fungal agents accompanying with cutaneous lesions of dogs suffering from Canine Visceral Leishmaniasis (CVL). Sterile swap samples were taken from cutaneous lesions inspected of ears, dorsal, collar, pectoral, inguinal and interdigital spaces of 20 dogs, in which diagnosis were based on a combination of clinical symptoms, anti-leishmania antibody titers by use of Immunofluorescence antibody test (IFAT), and dogs were further classified according to the Leishvet Guidelines involving serological, hematological, serum biochemical, and urinalysis. Swap samples were inoculated to culture media for isolation and identification of bacterial and mycotic agents. 48 Staphylococcus aureus, 4 Bacillus cereus, 8 Staphylococcus epidermidis, 24 Candida albicans, 24 Microsporium canis and 4 Aspergillus niger were isolated and identified in both group of dogs. Regarding antibiotic susceptibility test, the isolates were found 100% susceptible to cefoperazone and amoxicillin-clavulanic acid, 53% to danofloxacin, 46% of the isolates were susceptible to enrofloxacin, and all of the isolates were resistant (100%) to penicillin G and gentamicin. In conclusion, the antibacterial and antifungal therapy should be provided in accordance with antibiotic susceptibility tests in skin lesions of dogs suffering with CVL.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
